secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoHealth, Inc. (GOCO)
CIK:        0001808220
Form:       8-K
Filed at:   2022-05-27T23:59:59+00:00
Accession:  0001808220-22-000052
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

GoHealth receives Nasdaq minimum bid price deficiency notice; appoints David Fisher to board
--------------------------------------------------------------------------------

- Received Nasdaq notice for bid price below $1.00 for 30 consecutive days; compliance period through Nov 21, 2022.
- Company may pursue reverse stock split to regain compliance, subject to board and stockholder approval.
- David Fisher appointed as Class I director and Audit Committee chair; Helene Gayle resigned with no disagreement.
- At annual meeting, stockholders approved all proposals: directors, EY ratification, say-on-pay every year, plan amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808220/000180822022000052/0001808220-22-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808220/000180822022000052/goco-20220525.htm
  HTML page:      https://secwatch.observer/filing/0001808220-22-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer